André Tadić

2.7k total citations
43 papers, 1.9k citations indexed

About

André Tadić is a scholar working on Pharmacology, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, André Tadić has authored 43 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 16 papers in Psychiatry and Mental health and 12 papers in Cognitive Neuroscience. Recurrent topics in André Tadić's work include Treatment of Major Depression (21 papers), Bipolar Disorder and Treatment (12 papers) and Tryptophan and brain disorders (9 papers). André Tadić is often cited by papers focused on Treatment of Major Depression (21 papers), Bipolar Disorder and Treatment (12 papers) and Tryptophan and brain disorders (9 papers). André Tadić collaborates with scholars based in Germany, United States and Switzerland. André Tadić's co-authors include Stefanie Wagner, Klaus Lieb, Norbert Dahmen, Isabella Helmreich, Nadine Dreimüller, Carmen Maria Olivera Müller, Michael Huß, Oliver Tüscher, Alexandra Sebastian and Christoph Hiemke and has published in prestigious journals such as PLoS ONE, Biological Psychiatry and Journal of Affective Disorders.

In The Last Decade

André Tadić

43 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
André Tadić Germany	24	646	474	434	417	416	43	1.9k
Stefano Porcelli Italy	24	603 0.9×	288 0.6×	396 0.9×	417 1.0×	750 1.8×	72	2.0k
Min-Soo Lee South Korea	24	396 0.6×	585 1.2×	329 0.8×	319 0.8×	458 1.1×	72	2.0k
Dolors Puigdemont Spain	23	392 0.6×	477 1.0×	503 1.2×	231 0.6×	454 1.1×	48	2.0k
Matthew S. Milak United States	24	763 1.2×	563 1.2×	278 0.6×	550 1.3×	312 0.8×	49	2.0k
Isabelle Massat Belgium	25	548 0.8×	568 1.2×	306 0.7×	375 0.9×	890 2.1×	61	2.0k
Tae‐Youn Jun South Korea	29	528 0.8×	270 0.6×	381 0.9×	568 1.4×	767 1.8×	125	2.4k
Gustavo Kinrys United States	25	472 0.7×	325 0.7×	474 1.1×	287 0.7×	614 1.5×	52	1.9k
Sakina J. Rizvi Canada	26	610 0.9×	651 1.4×	650 1.5×	378 0.9×	720 1.7×	63	2.8k
Lawrence T. Park United States	20	894 1.4×	342 0.7×	290 0.7×	890 2.1×	260 0.6×	35	1.9k
Claus Normann Germany	33	454 0.7×	915 1.9×	441 1.0×	342 0.8×	795 1.9×	117	3.1k

Countries citing papers authored by André Tadić

Since Specialization

Citations

This map shows the geographic impact of André Tadić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Tadić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Tadić more than expected).

Fields of papers citing papers by André Tadić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Tadić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Tadić. The network helps show where André Tadić may publish in the future.

Co-authorship network of co-authors of André Tadić

This figure shows the co-authorship network connecting the top 25 collaborators of André Tadić. A scholar is included among the top collaborators of André Tadić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Tadić. André Tadić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Engelmann, Jan, Stefanie Wagner, Daniel Wollschläger, et al.. (2019). Higher BDNF plasma levels are associated with a normalization of memory dysfunctions during an antidepressant treatment. European Archives of Psychiatry and Clinical Neuroscience. 270(2). 183–193. 11 indexed citations

Dreimüller, Nadine, Klaus Lieb, André Tadić, et al.. (2019). Body mass index (BMI) in major depressive disorder and its effects on depressive symptomatology and antidepressant response. Journal of Affective Disorders. 256. 524–531. 43 indexed citations

Wagner, Stefanie, Isabella Helmreich, Daniel Wollschläger, et al.. (2018). Early improvement of executive test performance during antidepressant treatment predicts treatment outcome in patients with Major Depressive Disorder. PLoS ONE. 13(4). e0194574–e0194574. 14 indexed citations

Lieb, Klaus, Nadine Dreimüller, Stefanie Wagner, et al.. (2018). BDNF Plasma Levels and BDNF Exon IV Promoter Methylation as Predictors for Antidepressant Treatment Response. Frontiers in Psychiatry. 9. 511–511. 39 indexed citations

Wagner, Stefanie, André Tadić, Alice Engel, et al.. (2017). A combined marker of early non-improvement and the occurrence of melancholic features improve the treatment prediction in patients with Major Depressive Disorders. Journal of Affective Disorders. 221. 184–191. 7 indexed citations

Wagner, Stefanie, Alice Engel, Jan Engelmann, et al.. (2017). Early improvement as a resilience signal predicting later remission to antidepressant treatment in patients with Major Depressive Disorder: Systematic review and meta-analysis. Journal of Psychiatric Research. 94. 96–106. 59 indexed citations

Tadić, André, Daniel Wachtlin, Thomas Berger, et al.. (2016). Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression – The EMC trial. European Neuropsychopharmacology. 26(4). 705–716. 36 indexed citations

Singh, Jaskaran, Maggie Fedgchin, Ella Daly, et al.. (2015). Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study. Biological Psychiatry. 80(6). 424–431. 320 indexed citations

Helmreich, Isabella, Stefanie Wagner, J. König, et al.. (2014). Hamilton depression rating subscales to predict antidepressant treatment outcome in the early course of treatment. Journal of Affective Disorders. 175. 199–208. 11 indexed citations

10.

Dreimüller, Nadine, Konrad F. Schlicht, Stefanie Wagner, et al.. (2011). Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression. Neuropharmacology. 62(1). 264–269. 52 indexed citations

11.

Tadić, André, Stefanie Wagner, Stanislav Gorbulev, et al.. (2011). Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder. BMC Psychiatry. 11(1). 16–16. 23 indexed citations

12.

Tadić, André, Stefanie Wagner, Aleksandra Dragičević, et al.. (2011). Association Between Citalopram Serum Levels and Clinical Improvement of Patients With Major Depression. Journal of Clinical Psychopharmacology. 31(3). 281–286. 31 indexed citations

13.

Vogel, Friederike, Stefanie Wagner, Ömür Başkaya, et al.. (2011). Variable number of tandem repeat polymorphisms of the arginine vasopressin receptor 1A gene and impulsive aggression in patients with borderline personality disorder. Psychiatric Genetics. 22(2). 105–106. 12 indexed citations

14.

Helmreich, Isabella, Stefanie Wagner, Roland Mergl, et al.. (2011). Sensitivity to changes during antidepressant treatment: a comparison of unidimensional subscales of the Inventory of Depressive Symptomatology (IDS-C) and the Hamilton Depression Rating Scale (HAMD) in patients with mild major, minor or subsyndromal depression. European Archives of Psychiatry and Clinical Neuroscience. 262(4). 291–304. 30 indexed citations

15.

Helmreich, Isabella, Stefanie Wagner, Roland Mergl, et al.. (2010). The Inventory of Depressive Symptomatology (IDS-C28) is more sensitive to changes in depressive symptomatology than the Hamilton Depression Rating Scale (HAMD17) in patients with mild major, minor or subsyndromal depression. European Archives of Psychiatry and Clinical Neuroscience. 261(5). 357–367. 20 indexed citations

16.

Tadić, André, Amelie Elsäßer, Niels Storm, et al.. (2010). Association analysis between gene variants of the tyrosine hydroxylase and the serotonin transporter in borderline personality disorder. The World Journal of Biological Psychiatry. 11(1). 45–58. 12 indexed citations

17.

Tadić, André, Amelie Elsäßer, Anja Victor, et al.. (2009). Association analysis of serotonin receptor 1B (HTR1B) and brain-derived neurotrophic factor gene polymorphisms in borderline personality disorder. Journal of Neural Transmission. 116(9). 1185–1188. 15 indexed citations

18.

Tadić, André, et al.. (2009). Gender Differences in Axis I and Axis II Comorbidity in Patients with Borderline Personality Disorder. Psychopathology. 42(4). 257–263. 74 indexed citations

19.

Tadić, André. (2008). Association analysis between variants of the interleukin-1β and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression. Neuropsychiatric Disease and Treatment. 4(1). 269–269. 29 indexed citations

20.

Tadić, André, Anja Victor, Ömür Başkaya, et al.. (2008). Interaction between gene variants of the serotonin transporter promoter region (5‐HTTLPR) and catechol O‐methyltransferase (COMT) in borderline personality disorder. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 150B(4). 487–495. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact